CRON
Company Description
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Track Record
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 193.36M | 117.61M | 87.24M | 86.75M | 64.56M | 46.72M | 23.75M | 12.12M | 3.25M | 412,322 | 3.40M | (665,000) |
| Net Income | (9.45M) | 41.08M | (73.96M) | (168.73M) | (396.11M) | (73.14M) | 1.17B | (21.64M) | (1.48M) | (885,000) | 278,279 | (4.15M) |
| EPS | -0.02 | 0.11 | -0.19 | -0.45 | -1.07 | -0.21 | 7.92 | -0.08 | -0.01 | -0.01 | 0.01 | -0.13 |
| Free Cash Flow | 151,611 | 5.69M | (46.26M) | (93.98M) | (165.88M) | (180.26M) | (168.96M) | (91.41M) | (38.37M) | (5.95M) | N/A | N/A |
| FCF / Share | 0.00 | 0.01 | -0.11 | -0.25 | -0.45 | -0.51 | -0.54 | -0.51 | -0.28 | -0.10 | N/A | N/A |
| Operating CF | 26.32M | 18.84M | (42.84M) | (88.95M) | (153.62M) | (144.87M) | (130.01M) | (7.15M) | (4.41M) | (4.82M) | N/A | N/A |
| Total Assets | 1.20B | 1.17B | 1.14B | 1.21B | 1.40B | 1.93B | 2.09B | 191.71M | 80.34M | 31.92M | N/A | N/A |
| Total Debt | 1.51M | 2.02M | 2.55M | 3.88M | 9.81M | 9.81M | 7.11M | 15.38M | 4.27M | 2.98M | N/A | N/A |
| Cash & Equiv | 791.79M | 858.80M | 669.29M | 764.64M | 886.97M | 1.08B | 1.20B | 23.96M | 7.32M | 2.58M | N/A | N/A |
| Book Value | 1.09B | 1.06B | 1.10B | 1.14B | 1.34B | 1.71B | 1.75B | 155.29M | 68.68M | 25.06M | N/A | N/A |
| Return on Equity | -0.01 | 0.04 | -0.07 | -0.15 | -0.30 | -0.04 | 0.67 | -0.14 | -0.02 | -0.04 | N/A | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 44.58M | 91.31M | 36.34M | 33.45M | 32.26M | 30.30M | 34.26M | 27.76M | 25.29M | 23.91M | 24.81M | 19.02M |
| Net Income | 13.56M | (1.82M) | 25.96M | (39.71M) | 6.12M | 43.73M | 8.35M | (8.76M) | (2.24M) | (44.79M) | (1.64M) | (8.36M) |
| EPS | 0.04 | -0.00 | 0.07 | -0.10 | 0.02 | 0.12 | 0.02 | -0.02 | -0.01 | -0.12 | -0.00 | -0.02 |
| Free Cash Flow | 8.90M | 9.87M | 8.72M | (1.02M) | (17.45M) | 4.01M | 5.05M | 828,000 | (4.20M) | 15.02M | (508,000) | (12.28M) |
| FCF / Share | 0.02 | 0.03 | 0.02 | -0.00 | -0.05 | 0.01 | 0.01 | 0.00 | -0.01 | 0.04 | -0.00 | -0.03 |
| Operating CF | 10.75M | 12.03M | 13.31M | 2.82M | (2.10M) | 7.72M | 11.58M | 1.74M | (2.20M) | 16.82M | (183,000) | (11.77M) |
| Total Assets | 1.18B | 1.20B | 1.18B | 1.18B | 1.15B | 1.17B | 1.18B | 1.09B | 1.11B | 1.14B | 1.56B | 1.55B |
| Total Debt | 1.32M | 1.51M | 1.74M | 2.01M | 1.82M | 2.02M | 1.85M | 1.99M | 2.26M | 2.55M | 3.67M | 4.27M |
| Cash & Equiv | 824.56M | 791.79M | 784.17M | 794.42M | 797.82M | 858.80M | 862.03M | 848.19M | 855.11M | 669.29M | 776.45M | 542.38M |
| Book Value | 1.08B | 1.09B | 1.08B | 1.08B | 1.07B | 1.06B | 1.08B | 1.06B | 1.08B | 1.10B | 1.52B | 1.51B |
| Return on Equity | 0.01 | -0.00 | 0.02 | -0.04 | 0.01 | 0.04 | 0.01 | -0.01 | -0.00 | -0.04 | -0.00 | -0.01 |
